Skip to main content
Fig. 3 | Thrombosis Journal

Fig. 3

From: Vitamin K antagonist use: evidence of the difficulty of achieving and maintaining target INR range and subsequent consequences

Fig. 3

Costs Associated with In Range and Out of Range INRs. Adapted from data from a US Veterans Administration dataset [46] where the total costs are displayed in blue and the constituent costs of inpatient, outpatient, and outpatient pharmacy costs are in red, green, and purple, respectively. The total costs in the therapeutic INR group is significantly lower than those with abnormally low or high INR groups. Note that the highest costs were associated with suboptimal INR values (i.e., INR <2.0)

Back to article page

Thrombosis Journal

ISSN: 1477-9560

Contact us